Chargement en cours...
Immunosuppressive therapy with rituximab in common variable immunodeficiency
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary antibody deficiency in adulthood and is characterized by the marked reduction of IgG and IgA serum levels. Thanks to the successful use of polyvalent immunoglobulin replacement therapy to treat and prevent recurrent inf...
Enregistré dans:
| Publié dans: | Clin Mol Allergy |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501382/ https://ncbi.nlm.nih.gov/pubmed/31080365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-019-0113-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|